| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0006 | 1 |